淋巴结检出数<15与食管切除术生存率降低相关,并可作为质量指标
单中心回顾性分析2010年1月1日至2020年12月31日397例根治性食管切除术患者,评估淋巴结检出数与淋巴结比率(LNR)对生存的影响。切缘状态(HR 1.80)、淋巴结检出数<15(HR 1.98)和LNR升高(HR 8.16)预测生存;微创食管切除术(MIE)淋巴结检出数高于开放手术(30.7 vs 25.3);新辅助放化疗患者淋巴结检出数低于无新辅助治疗和新辅助化疗者(26.4 vs 30.6 vs 36.8);LNR<0.05与生存获益相关。
要点
- 切缘状态、淋巴结检出数<15和LNR升高与总生存降低相关。
- MIE淋巴结检出数高于开放手术(30.7 vs 25.3)。
- 新辅助放化疗者淋巴结检出数低于无新辅助治疗和新辅助化疗者(26.4 vs 30.6 vs 36.8)。
核心结论
- 规范的淋巴结清扫与生存改善相关;淋巴结检出数低和LNR高与总生存降低相关。
- LNR<0.05与显著生存获益相关。
- 淋巴结检出数至少15枚应继续作为标准治疗。
研究设计与样本
- 单中心回顾性研究,纳入2010年1月1日至2020年12月31日接受根治性食管切除术的患者(Stage 1-4均纳入),共397例,其中288例接受微创食管切除术(MIE)。
主要发现
- 切缘状态(HR 1.80;95% CI 1.15-2.83;P<.01)、淋巴结检出数<15(HR 1.98;95% CI 1.29-3.04;P=.002)和LNR升高(HR 8.16;95% CI 2.89-23.06;P<.001)预测生存。
- MIE淋巴结检出数高于开放手术(30.7 vs 25.3,P<.001)。
- 新辅助放化疗患者淋巴结检出数低于无新辅助治疗和新辅助化疗者(26.4 vs 30.6 vs 36.8,P<.001)。
- 回归分析确定LNR<0.05与生存获益相关。
关键数值与推荐
- 指南建议食管切除术中至少切除并检查15枚淋巴结。
- LNR<0.05与显著生存获益相关。
临床怎么用
- 淋巴结检出数至少15枚应继续作为标准治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical resection after neoadjuvant therapy remains the cornerstone of curative management of esophageal adenocarcinoma and is frequently used for squamous cell carcinoma. The optimal extent of lymphadenectomy and whether increasing lymph node yields confer a survival benefit remains unclear. Guidelines suggest resecting and examining a minimum of 15 lymph nodes at esophagectomy. This study assessed the impact of lymph node yield and lymph node ratio (LNR) on survival, identifying factors influencing nodal yield and radicality of resection. METHODS: All patients undergoing esophagectomy with curative intent at a single institution (stage 1-4 inclusive) from January 1, 2010, to December 31, 2020, were reviewed. Clinical and pathologic variables were interrogated. LNR was calculated by dividing positive lymph nodes by the total nodes resected. RESULTS: Esophagectomy was performed in 397 patients, with 288 undergoing minimally invasive esophagectomy (MIE). Margin status (hazard ratio [HR], 1.80; 95% CI, 1.15-2.83; P < .01), nodal yield <15 (HR, 1.98; 95% CI, 1.29-3.04; P = .002), and elevated LNR (HR, 8.16; 95% CI, 2.89-23.06; P < .001) predicted survival. MIE had higher nodal yields compared with open procedures (30.7 vs 25.3, P < .001). Patients undergoing neoadjuvant chemoradiotherapy had lower nodal yields compared with those with no neoadjuvant therapy and those with neoadjuvant chemotherapy (26.4 vs 30.6 vs 36.8, respectively; P < .001). Regression analysis determined a LNR of <0.05 was associated with a survival benefit. CONCLUSIONS: Textbook lymphadenectomy is associated with improved survival. Low lymph node yield and a high LNR are associated with reduced overall survival. A LNR of <0.05 is associated with significant survival benefit. A minimum nodal yield of 15 should remain the standard of care.
引用
- Bolger JC, Castro PP, Marwah A, et al. Nodal Yield <15 Is Associated With Reduced Survival in Esophagectomy and Is a Quality Metric. Ann Thorac Surg. 2023. PMID: 36918078. doi:10.1016/j.athoracsur.2023.02.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。